Candidat
Établissement
Titre |
Subvention |
Auer, Rebecca
Ottawa Hospital Research Institute
Oncolytic viruses for perioperative targeting of natural killer cells in cancer |
2012/2013 : $99,733
2013/2014 : $99,733 |
Collins, Colin
University of British Columbia
Computational discovery of biomarkers targets in prostate cancer |
2012/2013 : $91,960
2013/2014 : $91,960 |
Coomber, Brenda
University of Guelph
Predicting and improving responses of colorectal cancer patients to anti-VEGF therapy: TGF-beta modulation of endothelial VEGFR2 expression |
2012/2013 : $99,197
2013/2014 : $99,101 |
Ehrhardt, Goetz
University of Toronto
Biomarker discovery in multiple myeloma: novel applications for ancient antibodies |
2012/2013 : $99,645
2013/2014 : $99,645 |
Helgason, Cheryl
BC Cancer Agency (Vancouver)
Long non-coding RNA in prostate cancer |
2012/2013 : $71,670
2013/2014 : $64,165
2014/2015 : $64,165 |
Hieter, Philip
University of British Columbia
Synthetic cytotoxicity in genetic model systems to identify potential anti-cancer therapeutic regimes |
2012/2013 : $99,600
2013/2014 : $99,600 |
Husain, Amna
Mount Sinai Hospital
Online communication application for collaborative patient care in cancer |
2012/2013 : $100,000
2013/2014 : $97,750 |
Kane, Kevin
University of Alberta
Prostate cancer T cell immunomics: CTL array |
2012/2013 : $99,991
2013/2014 : $99,991 |
Korbelik, Mladen
BC Cancer Agency (Vancouver)
Photodynamic therapy treatment as a tool for generating cancer vaccines |
2012/2013 : $99,995
2013/2014 : $99,995 |
Liu, Fei-Fei
Ontario Cancer Institute/PMH
The blood-brain-bone (3B) triad of radiation-induced fatigue |
2012/2013 : $99,160
2013/2014 : $99,160 |
Loewen, Christopher
University of British Columbia
Small molecule antagonists of intracellular acid stress in cancer |
2012/2013 : $100,000
2013/2014 : $100,000 |
Minchinton, Andrew
BC Cancer Agency (Vancouver)
Using pharmacological GSK-3 inhibitors to target contact-derived drug-resistance in cancer |
2012/2013 : $99,756
2013/2014 : $99,756 |
Murphy, Leigh
University of Manitoba
Epigenetic-like codes for estrogen receptor alpha (ERa): ERa phosphorylation profiling ex vivo in human breast tumours |
2012/2013 : $100,000
2013/2014 : $98,150 |
Penn, Linda
Ontario Cancer Institute/PMH
A novel strategy to identify small-molecules regulating the Myc oncoprotein |
2012/2013 : $91,225
2013/2014 : $91,225 |
Pickering, J Geoffrey
University of Western Ontario
Stabilization of tumour vessels |
2012/2013 : $66,580
2013/2014 : $66,580
2014/2015 : $66,580 |
Rak, Janusz
The Research Institute of the McGill University Health Centre (RI-MUHC)
Age-specific antiangiogenic therapy |
2012/2013 : $100,000
2013/2014 : $100,000 |
Rosin, Miriam
BC Cancer Research Centre
HPV in tonsils: natural history of infection and role in oral cancers |
2012/2013 : $73,225
2013/2014 : $79,550
2014/2015 : $47,225 |
Saleh, Maya
McGill University
Host genetic determinants of colon cancer metastasis |
2012/2013 : $100,000
2013/2014 : $99,376 |
Shah, Sohrab
BC Cancer Agency (Vancouver)
Finding driver mutations in cancer through integrative profiling of mutational landscapes and transcriptional networks |
2012/2013 : $99,606
2013/2014 : $100,000 |
Singh, Sheila
McMaster University
Identification of brain metastasis-initiating cells and regulators of brain metastasis from lung cancer |
2012/2013 : $99,878
2013/2014 : $100,000 |
Werbowetski-Ogilvie, Tamra
University of Manitoba
Using human embryonic stem cells to understand early molecular events during pediatric brain tumorigenesis |
2012/2013 : $94,391
2013/2014 : $85,444 |
Wrana, Jeffrey
Mount Sinai Hospital
Establishing a biological network strategy for personalizing cancer diagnosis, prognosis and drug development using genitourinary cancer as a model |
2012/2013 : $99,840
2013/2014 : $99,840 |
Zheng, Gang
Ontario Cancer Institute/PMH
Photodynamic molecular beacons: improving the quality of life for spinal metastases patients |
2012/2013 : $99,465
2013/2014 : $99,534 |